Jolley Asset Management’s GSK GSK Stock Holding History

Jolley Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-224	Closed	-$10K	–	185
2017 Q4	$10K	Sell	224 -74,130	-100%	-$3.42M	0.01%	147
2017 Q3	$3.77M	Buy	74,354 +8,225	+12%	+$417K	2.56%	22
2017 Q2	$3.56M	Buy	66,129 +1,795	+3%	+$95.7K	2.5%	24
2017 Q1	$3.39M	Buy	64,334 +2,103	+3%	+$107K	2.44%	26
2016 Q4	$3M	Buy	62,231 +4,905	+9%	+$242K	2.15%	28
2016 Q3	$3.09M	Sell	57,326 -7,655	-12%	-$420K	2.5%	26
2016 Q2	$3.52M	Buy	64,981 +470	+0.7%	+$24.8K	2.83%	15
2016 Q1	$3.27M	Buy	64,511 +5,810	+10%	+$289K	2.98%	13
2015 Q4	$2.96M	Sell	58,701 -206	-0.3%	-$10.5K	2.82%	18
2015 Q3	$2.83M	Sell	58,907 -79	-0.1%	-$4.11K	2.87%	18
2015 Q2	$3.07M	Sell	58,986 -602	-1%	-$33.9K	2.79%	21
2015 Q1	$3.44M	Buy	59,588 +6,445	+12%	+$369K	2.85%	19
2014 Q4	$2.84M	Sell	53,143 -582	-1%	-$32.6K	2.35%	27
2014 Q3	$3.09M	Buy	53,725 +8,952	+20%	+$549K	2.49%	28
2014 Q2	$2.99M	Sell	44,773 -785	-2%	-$53.1K	2.2%	30
2014 Q1	$3.04M	Buy	45,558 +903	+2%	+$61K	2.26%	28
2013 Q4	$2.98M	Buy	44,655 +469	+1%	+$30.4K	2.35%	27
2013 Q3	$2.77M	Sell	44,186 -36	-0.1%	-$2.32K	2.31%	27
2013 Q2	$2.76M	Buy	+44,222	New	+$2.81M	2.24%	29

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jolley Asset Management's GSK Position: Q1 2018 in Review

Jolley Asset Management sold out of GSK (GSK) in Q1 2018, closing a stake of 224 shares — an estimated $10K sold.

Jolley Asset Management first reported a position in GSK in Q2 2013 and held it in 19 quarters. The position peaked at $3.77M in Q3 2017. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

Jolley Asset Management reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
Jolley Asset Management sold 224 GSK shares in Q1 2018, an estimated $10K.
Jolley Asset Management first reported a position in GSK in Q2 2013 and held it in 19 quarters.
Jolley Asset Management's GSK position peaked at $3.77M in Q3 2017.
778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Jolley Asset Management's 13F filing for Q1 2018, filed 13 Apr 2018.